Title : Phase 1 study of abemaciclib, an inhibitor of CDK 4 and 6, as a single agent for Japanese patients with advanced cancer.

Pub. Date : 2016 Aug

PMID : 27312735






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Phase 1 study of abemaciclib, an inhibitor of CDK 4 and 6, as a single agent for Japanese patients with advanced cancer. abemaciclib cyclin dependent kinase 4 Homo sapiens